These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12176500)

  • 1. Excellent results following 3 years of tacrolimus immunosuppression in kidney transplantation recipients in Japan: overall analysis of more than 1000 patients.
    Takahara S; Takahashi K; Uchida K; Oshima S; Toma H; Sonoda T;
    Transplant Proc; 2002 Aug; 34(5):1597-9. PubMed ID: 12176500
    [No Abstract]   [Full Text] [Related]  

  • 2. Outcome of kidney transplantation from non-heart-beating donors followed by tacrolimus immunosuppression in japan.
    Tanabe K; Takahashi K; Takahara S; Uchida K; Oshima S; Toma H; Sonoda T;
    Transplant Proc; 2002 Aug; 34(5):1580-2. PubMed ID: 12176493
    [No Abstract]   [Full Text] [Related]  

  • 3. Excellent 3-year results following living-donor kidney transplantation and tacrolimus immunosuppression in Japan.
    Uchida K; Takahashi K; Takahara S; Oshima S; Toma H; Sonoda T;
    Transplant Proc; 2002 Aug; 34(5):1606-7. PubMed ID: 12176503
    [No Abstract]   [Full Text] [Related]  

  • 4. Primary tacrolimus immunosuppression in kidney recipients considered "higher immunologic risk".
    Braun F; Lorf T; Schütz E; Canelo R; Hanack U; Döpkens K; Sattler B; Grupp C; Ringe B
    Transplant Proc; 2000 Nov; 32(7):2535. PubMed ID: 11120281
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term comparison of tacrolimus and cyclosporine-based immunosuppression in kidney recipients with grafts from non-heart-beating cadaver donor.
    Kinukawa T; Ohshima S; Ono Y; Fujita T; Hattori R; Tanaka K
    Transplant Proc; 1998 Jun; 30(4):1227-9. PubMed ID: 9636498
    [No Abstract]   [Full Text] [Related]  

  • 6. Primary tacrolimus immunosuppression in kidney recipients considered "higher immunological risk".
    Braun F; Lorf T; Schütz E; Canelo R; Hanack U; Döpkens K; Sattler B; Grupp C; Ringe B
    Transplant Proc; 2000 Nov; 32(7):1688. PubMed ID: 11119893
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term outcome of tacrolimus in cadaveric kidney transplantation from non-heart-beating donors.
    Fukuhara N; Ono Y; Kinukawa T; Hattori R; Nishiyama N; Yamada S; Kamihira O; Ohshima S
    Transplant Proc; 2002 Aug; 34(5):1577-9. PubMed ID: 12176492
    [No Abstract]   [Full Text] [Related]  

  • 8. Primary low-dose tacrolimus immunosuppressive prophylaxis for high-risk kidney transplant recipients.
    Braun F; Lorf T; Grupp C; Schütz E; Sattler B; Canelo R; Müller GA; Ringe B
    Transplant Proc; 1998 Jun; 30(4):1221-3. PubMed ID: 9636496
    [No Abstract]   [Full Text] [Related]  

  • 9. Non-heart-beating donor kidney transplantation under tacrolimus immunosuppression.
    Toda F; Tanabe K; Tokumoto T; Ishikawa N; Koga S; Ito S; Yagisawa T; Toma H
    Transplant Proc; 2000 Nov; 32(7):1726-9. PubMed ID: 11119909
    [No Abstract]   [Full Text] [Related]  

  • 10. Tacrolimus as a primary immunosuppressive therapy in cadaveric renal transplantation: five years' experience at a single center.
    Schneeberger H; Zanker B; Hillebrand G; Illner WD; Rothenpieler U; Land W
    Transplant Proc; 1998 Jun; 30(4):1598-9. PubMed ID: 9636642
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful treatment of 115 pediatric renal transplant recipients with tacrolimus-based immunosuppressive therapy: a 7-year multicenter study in Japan.
    Hasegawa A; Oshima S; Takahashi K; Uchida K; Ito K; Sonoda T
    Transplant Proc; 2005 May; 37(4):1769-70. PubMed ID: 15919460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Living-related versus living-unrelated kidney transplantation using tacrolimus initial immunosuppression.
    Braun F; Canelo R; Lorf T; Schütz E; Grupp C; Müller GA; Ringe B
    Transplant Proc; 2000 Feb; 32(1):115-6. PubMed ID: 10700989
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful results after 3 years' tacrolimus immunosuppression in ABO-incompatible kidney transplantation recipients in Japan.
    Takahashi K; Takahara S; Uchida K; Oshima S; Toma H; Sonoda T;
    Transplant Proc; 2002 Aug; 34(5):1604-5. PubMed ID: 12176502
    [No Abstract]   [Full Text] [Related]  

  • 14. Outcome of tacrolimus-treated renal transplantation from elderly donors.
    Goto Y; Tanabe K; Tokumoto T; Kondo T; Ishikawa N; Toma H
    Transplant Proc; 2000 Nov; 32(7):1723-5. PubMed ID: 11119908
    [No Abstract]   [Full Text] [Related]  

  • 15. Tacrolimus-based immunosuppression in pediatric renal transplantation.
    Jordan ML; Shapiro R; Scantlebury V; Vivas C; Ellis D; Lombardozzi-Lane S; Starzl TE
    Transplant Proc; 1999 Nov; 31(7A):29S-30S. PubMed ID: 10576039
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term renal retransplantation and graft survival rates at our center.
    Karakayali H; Moray G; Demirağ A; Arslan G; Köseoğlu F; Akkoç H; Bilgin N
    Transplant Proc; 1998 May; 30(3):762-3. PubMed ID: 9595087
    [No Abstract]   [Full Text] [Related]  

  • 17. Tacrolimus versus cyclosporine as primary prophylactic therapy after cadaveric renal transplant: two-year survival study.
    Wong KM; Cheung CY; Chan YH; Chak WL; Choi KS; Chau KF; Li CS
    Transplant Proc; 2000 Nov; 32(7):1721-2. PubMed ID: 11119907
    [No Abstract]   [Full Text] [Related]  

  • 18. Safety analysis following tacrolimus immunosuppression in renal transplant recipients in Japan: 3-year results in over 1000 patients.
    Yoshimura N; Takahara S; Uchida K; Takahashi K; Oshima S; Toma H; Sonoda T;
    Transplant Proc; 2002 Aug; 34(5):1600-3. PubMed ID: 12176501
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunosuppression using tacrolimus/mycophenolate versus neoral/mycophenolate following kidney transplantation: a single-center experience.
    Urbizu JM; Amenabar JJ; Gomez-Ullate P; Zarraga S; Lampreabe I
    Transplant Proc; 2002 Feb; 34(1):87-8. PubMed ID: 11959197
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetics of tacrolimus primary immunosuppression in kidney transplant recipients.
    Braun F; Schütz E; Peters B; Talaulicar R; Grupp C; Undre N; Schäfer A; Armstrong VW; Oellerich M; Ringe B
    Transplant Proc; 2001 May; 33(3):2127-8. PubMed ID: 11377473
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.